Singapore markets closed

CollPlant Biotechnologies Ltd. (CLGN)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
5.89+0.41 (+7.48%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
10,959
10,959
299
15,641
6,137
Cost of revenue
1,991
1,991
400
2,005
3,002
Gross profit
8,968
8,968
-101
13,636
3,135
Operating expenses
Research development
10,484
10,484
10,255
7,631
4,065
Selling general and administrative
5,996
5,996
6,741
5,940
4,669
Total operating expenses
16,480
16,480
16,996
13,571
8,734
Operating income or loss
-7,512
-7,512
-17,097
65
-5,599
Total other income/expenses net
-285
-285
-115
-10
-141
Income before tax
-7,019
-7,019
-16,925
237
-5,774
Income from continuing operations
-7,019
-7,019
-16,925
237
-5,774
Net income
-7,019
-7,019
-16,925
237
-5,774
Net income available to common shareholders
-7,019
-7,019
-16,925
237
-5,774
Basic EPS
-0.59
-0.62
-1.53
0.02
-0.84
Diluted EPS
-0.59
-0.62
-1.53
0.02
-0.84
Basic average shares
11,319
11,389
11,033
9,969
6,887
Diluted average shares
11,319
11,389
11,033
11,967
6,887